- Comprehensive Assay Portfolio Human & ortholog cell lines, eXpress Kits, qualified bioassays, & detection reagents - Multiple MOA Formats Measure ligand activity via cAMP signaling, -arrestin recruitment, & receptor internalization - Regulatory-ready Solutions Qualified bioassays for potency & bio-identity testing Find out how numerous global biologics & biosimilar programs leverage these solutions to accelerate the development of obesity & diabetes therapeutics
Start your transformation today and restore your skins natural glow from the inside out
The official tesamorelin FDA label (prescribing information for Egrifta and Egrifta WR) reflects tesamorelin availability in 2026 through Theratechnologies, with no generic competition on market
You add 1mL of water because that is what you always add
"I'm all about body neutrality, they continued
Journal Of The American College Of Cardiology 2001, 38: 199-205